Voriconazole [clinicaltrials_resource:4dfb5902b1809bc42e6a923aded1e87e]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00331643 [clinicaltrials_resource:04e94b8a43da0e6fb95715b99650bb9c]eligibility for clinicaltrials:NCT00363272 [clinicaltrials_resource:0b0953eac77c878adc10605e4ff5b90a]eligibility for clinicaltrials:NCT01835145 [clinicaltrials_resource:22853b78666e9653a2ef02f18dcab961]eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00118157 [clinicaltrials_resource:38c27da684633d4e18d079b4d14c3854]eligibility for clinicaltrials:NCT00617708 [clinicaltrials_resource:5779b97f6e8f19f4261bc4fbf6ffca8f]eligibility for clinicaltrials:NCT00096499 [clinicaltrials_resource:a07408bbc65c5b2266e419ce0526be68]eligibility for clinicaltrials:NCT02066181 [clinicaltrials_resource:b75bbb3aebffbab9512c0286dff621a7]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis [clinicaltrials:NCT00001646]An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [clinicaltrials:NCT00001757]An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [clinicaltrials:NCT00001810]Voriconazole to Treat Fungal Infections [clinicaltrials:NCT00001940]Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis [clinicaltrials:NCT00003031]Voriconazole to Prevent Systemic Fungal Infections in Children [clinicaltrials:NCT00005912]A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia [clinicaltrials:NCT00008840]Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections [clinicaltrials:NCT00015665]Blood and Marrow Transplant Clinical Research Network [clinicaltrials:NCT00023530]Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections [clinicaltrials:NCT00059878]Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [clinicaltrials:NCT00066599]clinicaltrials:NCT00075803Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00079222]Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy [clinicaltrials:NCT00136968]clinicaltrials:NCT00143312clinicaltrials:NCT00150345Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia [clinicaltrials:NCT00152594]clinicaltrials:NCT00159822A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. [clinicaltrials:NCT00163111]A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children [clinicaltrials:NCT00174473]Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism [clinicaltrials:NCT00175994]Voriconazole as Prophylaxis for Liver Transplant Recipients [clinicaltrials:NCT00177788]Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients [clinicaltrials:NCT00177827]clinicaltrials:NCT00238355A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections [clinicaltrials:NCT00288197]clinicaltrials:NCT00289991clinicaltrials:NCT00300677Intravenous Voriconazole in Patients With Renal Compromise [clinicaltrials:NCT00332410]clinicaltrials:NCT00353158Voriconazole Blood Levels and Toxicity [clinicaltrials:NCT00359541]An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study [clinicaltrials:NCT00371605]clinicaltrials:NCT00412893clinicaltrials:NCT00413218clinicaltrials:NCT00418951A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis [clinicaltrials:NCT00423163]Voriconazole as Prophylactic Therapy in Lung Transplant Recipients [clinicaltrials:NCT00455364]clinicaltrials:NCT00496197clinicaltrials:NCT00531479clinicaltrials:NCT00548262clinicaltrials:NCT00556998
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Voriconazole [clinicaltrials_resource:4dfb5902b1809bc42e6a923aded1e87e]
Bio2RDF identifier
4dfb5902b1809bc42e6a923aded1e87e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4dfb5902b1809bc42e6a923aded1e87e
identifier
clinicaltrials_resource:4dfb5902b1809bc42e6a923aded1e87e
title
Voriconazole
@en
type
label
Voriconazole [clinicaltrials_resource:4dfb5902b1809bc42e6a923aded1e87e]
@en